Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rome Therapeutics
Special Reports
The 2025 Biotech Graveyard
Biotechs, beware: You're in for a scare.
Darren Incorvaia
Oct 31, 2025 5:00am
Rome nears end of road with planned layoffs, strategic review
Sep 23, 2025 2:00pm
Scorpion taps new CEO, CMO—Chutes & Ladders
Jan 5, 2024 9:30am
Rome's 'dark genome' drug reduces autoimmune markers in mice
Nov 17, 2023 1:03pm
Rome builds out investor syndicate with J&J, BMS
Sep 12, 2023 7:00am
Biogen taps new board chair—Chutes & Ladders
Mar 10, 2023 9:30am
